0001780610-21-000001.txt : 20210806 0001780610-21-000001.hdr.sgml : 20210806 20210805183315 ACCESSION NUMBER: 0001780610-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210806 DATE AS OF CHANGE: 20210805 EFFECTIVENESS DATE: 20210806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoSenX, Inc. CENTRAL INDEX KEY: 0001780610 IRS NUMBER: 823491338 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-409051 FILM NUMBER: 211149970 BUSINESS ADDRESS: STREET 1: 800 5TH AVE STE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206-880-1166 MAIL ADDRESS: STREET 1: 800 5TH AVE STE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 D 1 primary_doc.xml X0708 D LIVE 0001780610 OncoSenX, Inc. 701 Fifth Avenue Suite 4200 SEATTLE WA WASHINGTON 98104 206-880-1166 DELAWARE Oisin Oncology, Inc. None Corporation true 2017 Gary Hudson 701 Fifth Avenue Suite 4200 Seattle WA WASHINGTON 98104 Executive Officer Director Promoter John Lewis 701 Fifth Avenue Suite 4200 Seattle WA WASHINGTON 98104 Executive Officer Director Promoter Matthew Scholz 701 Fifth Avenue Suite 4200 Seattle WA WASHINGTON 98104 Executive Officer Director Promoter Stephen Hilbert 701 Fifth Avenue Suite 4200 Seattle WA WASHINGTON 98104 Executive Officer Eric Garcia 701 Fifth Avenue Suite 4200 Seattle WA WASHINGTON 98104 Executive Officer Other Technology Decline to Disclose 06b false 2021-07-22 false true false 0 5000000 650000 4350000 false 8 0 0 0 false OncoSenX, Inc. /s/ Matthew Scholz Matthew Scholz Chief Executive Officer of the Issuer 2021-08-05